Ken Griffin Generation Bio Co. Put Options Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.64 - $4.35 $528 - $869
200 New
200 $0
Q3 2023

Nov 14, 2023
SELL
$3.65 - $6.9 $2,920 - $5,520
-800 Reduced 14.81%
4,600 $17,000
Q2 2023

Aug 14, 2023
BUY
$3.5 - $5.67 $10,850 - $17,577
3,100 Added 134.78%
5,400 $29,000
Q1 2023

May 15, 2023
BUY
$3.61 - $7.01 $4,693 - $9,113
1,300 Added 130.0%
2,300 $9,000
Q4 2022

Feb 14, 2023
BUY
$3.66 - $6.77 $3,660 - $6,770
1,000 New
1,000 $3,000

Others Institutions Holding GBIO

# of Institutions
76
Shares Held
49.6M
Call Options Held
0
Put Options Held
0
View Full List

About Generation Bio Co.

GBIO Quotes by TradingView
  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $79.7M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email